INAB - IN8bio Inc Stock Price, Fair Value and News

$0.25+0.01 (+4.17%)

Delayed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

INAB Price Action

Last 7 days

-10.7%

Last 30 days

-21.9%

Last 90 days

-19.3%

Trailing 12 Months

-80.6%

INAB RSI Chart

INAB Valuation

Market Cap

18.1M

Price/Earnings (Trailing)

-0.57

Price/Free Cashflow

-0.72

INAB Price/Earnings (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

INAB Fundamentals

INAB Earnings

Earnings (TTM)

-31.9M

Earnings Growth (Yr)

1.16%

Earnings Growth (Qtr)

17.88%

INAB Profitability

Return on Equity

-371.16%

Return on Assets

-199.64%

Free Cashflow Yield

-138.19%

INAB Investor Care

Shares Dilution (1Y)

126.57%

Diluted EPS (TTM)

-0.74

Revenue & Growth

About IN8bio Inc

IN8bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidates include INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of glioblastoma and solid tumors; INB-100, an allogeneic product candidate, which is in Phase I clinical trial to treat patients with acute leukemia undergoing hematopoietic stem cell transplantation; and INB-400, which is in Phase 2 clinical trial to treat newly diagnosed GBM. It also develops INB-300, INB-410, and INB-500 that are in preclinical Phase for treatment of various solid tumor cancers. The company was formerly known as Incysus Therapeutics, Inc. and changed its name to IN8bio, Inc. in August 2020. IN8bio, Inc. was incorporated in 2016 and is headquartered in New York, New York.

CEO	Mr. Tai-Wei Ho
WEBSITE	https://in8bio.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	29

IN8bio Inc Frequently Asked Questions

What is the ticker symbol for IN8bio Inc? What does INAB stand for in stocks?

INAB is the stock ticker symbol of IN8bio Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of IN8bio Inc (INAB)?

As of Fri Dec 20 2024, market cap of IN8bio Inc is 18.12 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of INAB stock?

You can check INAB's fair value in chart for subscribers.

Is IN8bio Inc a good stock to buy?

The fair value guage provides a quick view whether INAB is over valued or under valued. Whether IN8bio Inc is cheap or expensive depends on the assumptions which impact IN8bio Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for INAB.